macular degeneration

释义

黄斑部退化；

Age-Related Macular Degeneration Is the Leading Cause of Blindness . . .
Prevalence of age-related macular degeneration in the United States.
Ranibizumab for neovascular age-related macular degeneration.
Complement factor H polymorphism in age-related macular degeneration.
Complement factor H polymorphism and age-related macular degeneration.
Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration
MARINA Study Group : Ranibizumab for neovascular age-related macular degeneration
Complement factor H variant increases the risk of age-related macular degeneration.
Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.
Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year result...